Tag: Investors
Cannabis Weekly Round-Up: CEO stats revealed, canopy results disappoint

Cannabis producer Canopy Growth reports another billion-dollar loss

Better marijuana stock: Green thumb industries or Curaleaf?

Smarter Strategic Investments are likely ahead in the third wave of cannabis investing

Why marijuana legalization won’t solve the industry’s problems

Ross Gerber says Tesla is pushing ahead of competitors during COVID-19 pandemic

Take these steps to help prevent the Coronavirus from infecting your cannabis stocks

Pot stocks plunge after another round of disappointing earnings

The cannabis industry’s struggles could be great news for these companies

Cannabis and Coronavirus: HEXO delays financial statements, Canopy Growth closes stores

Aurora Cannabis is now a penny stock. Will it recover?

The capital that ate wellness is going to eat your mushrooms

3 marijuana stocks that could be millionaire-makers

Major Canadian pot companies facing proposed class-action lawsuits in the U.S.

Why marijuana dividend stock Innovative Industrial (IIPR) fell 18% in October

As Russian money poured into cannabis, Giuliani allies scrambled to partake

Weekly cannabis stock news: GW Pharmaceuticals blows past estimates

Better cannabis stock: Aphria vs. Charlotte’s Web

Pot stocks, ETFs, top news and data from the cannabis industry this week

Wall Street’s top pot analyst loves Cronos deal for Altria: ‘Unique entry into cannabis’

Barclays is making bigger bets in marijuana stocks
Say what? A marijuana stock buying back its shares

Is Aphria a marijuana house of cards or a bad-news buy?
12/7/18--Shares in Aphria Inc., the third-largest Canadian marijuana company, have crashed over 50% this week because of short-sellers. Since shares have fallen significantly, Aphria's management has taken notice and responded to the allegations calling the short report "a malicious and self-serving attempt to profit by manipulating Aphria's stock price at the expense of Aphria's shareholders." Read
Canopy Growth and 4 other cannabis stocks that look good here

Everything you need to know about investing in Canadian marijuana stocks

Oklahoma investors await marijuana industry regulations

4 niche marijuana stocks with massive market share

The marijuana stock that Wall Street likes the most

These three cannabis stocks have been hijacked by traders

Better Buy: Aphria Inc. vs. Aurora Cannabis Inc.

Institutional investors currently buzzing on marijuana stocks

Bruce Linton discusses deploying CA$5 billion, Canopy’s commitment to international growth
8/16
/18--Canopy Growth, a Canadian medical marijuana giant, is taking a massive 5 billion Canadian dollar ($3.8 billion) investment and going all in on worldwide medical and recreational cannabis business opportunities, the company’s CEO, Bruce Linton, said during an exclusive, wide-ranging question-and-answer session in Toronto. Constellation Brands – which owns, distributes, and markets 100 beer, wine, and spirits brands, announced this record-setting investment in Canopy Growth, the largest involving a marijuana company to date. Read

Corona beer giant puts $3.8 billion bet on US love of cannabis

Cronos, a marijuana producer, starts trading on the Nasdaq

Marijuana stocks rallied in December

Which pure-play marijuana stock will have the highest operating margin?

Big-name investors pour millions into marijuana — both medicinal and not

Marijuana sector leaders say they’ve met with TMX Group to discuss U.S. investments

L.A. investor is betting $100 million on legal weed

Who cares what Jeff Sessions does? These marijuana stocks should soar

Investor hopes to help others cash in on growing marijuana business

As more states legalize marijuana, investors and marketers line up

4 best marijuana stocks to play the green rush

Privateer raises $40M, exceeds $100M in total funding

Damian Marley invests in marijuana futures

SEC accuses marijuana-focused company, CEO of fraud

Conference promises ‘brutally honest’ advice on getting into the business

Cannabis attracting mainstream research analysts

Ganjapreneurs pitch 200 marijuana investors at investment event
